Previous proteomic studies [8] indicated the Hsp90 family having differential expression in adult obese NAFLD patients versus healthy control individuals, proposing them as potential biomarkers for NAFLD. The gene discussed is HSP90AA1; the disease is metabolic dysfunction-associated steatotic liver disease.